CDEK
← All organizations

Cambridge Antibody Technology

For profit
Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Aug 12, 2002

Last known activity

Jan 1, 2008

Acquired by AstraZeneca on Jan 1, 2006

Timeline

1980s

  1. Jan 1, 1989

    Cambridge Antibody Technology— Founded

1990s

  1. Jan 1, 1998

    Aptein— Acquired

2000s

  1. Jan 1, 2006

    AstraZeneca— Acquired By

Drugs by trial phase (4 distinct, 8 trials)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (8)

Details

Founded
Cambridge, GB Jan 1, 1989
Last known activity
Jan 1, 2008